These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8923565)

  • 61. The central anti-serotonin activity of zotepine, a new neuroleptic, in rats.
    Shimomura K; Satoh H; Hirai O; Mori J; Tomoi M; Terai T; Katsuki S; Motoyama Y; Ono T
    Jpn J Pharmacol; 1982 Jun; 32(3):405-12. PubMed ID: 6125612
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A capillary gas-liquid chromatographic method for the assay of the neuroleptic drug zotepine in human serum or plasma.
    Ulrich S; Meyer FP; Bogerts B
    J Pharm Biomed Anal; 1996 Feb; 14(4):441-9. PubMed ID: 8729643
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics and adverse effects of single doses of dothiepin in young and elderly subjects.
    Bareggi SR; Cavallaro R; Pirola R; Altamura AC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):163-70. PubMed ID: 2309034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Toxicological interactions involving psychiatric drugs and alcohol: an update.
    Tanaka E
    J Clin Pharm Ther; 2003 Apr; 28(2):81-95. PubMed ID: 12713604
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes.
    Stingl JC; Radermacher J; Wozniak J; Viviani R
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559326
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?
    Ito K; Chiba K; Horikawa M; Ishigami M; Mizuno N; Aoki J; Gotoh Y; Iwatsubo T; Kanamitsu S; Kato M; Kawahara I; Niinuma K; Nishino A; Sato N; Tsukamoto Y; Ueda K; Itoh T; Sugiyama Y
    AAPS PharmSci; 2002; 4(4):E25. PubMed ID: 12645997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.
    Desai HD; Seabolt J; Jann MW
    CNS Drugs; 2001; 15(6):469-94. PubMed ID: 11524025
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biotransformation of post-clozapine antipsychotics: pharmacological implications.
    Caccia S
    Clin Pharmacokinet; 2000 May; 38(5):393-414. PubMed ID: 10843459
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety evaluation of zotepine for the treatment of schizophrenia.
    Riedel M; Musil R; Seemüller F; Spellmann I; Möller HJ; Schennach-Wolff R
    Expert Opin Drug Saf; 2010 Jul; 9(4):659-66. PubMed ID: 20486863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacokinetics of zotepine and various factors affecting that of zotepine].
    Tanaka O
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Apr; 16(2):49-52. PubMed ID: 8905790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single oral dose kinetics of zotepine and its relationship to prolactin response and side effects.
    Tanaka O; Kondo T; Otani K; Yasui N; Tokinaga N; Kaneko S
    Ther Drug Monit; 1998 Feb; 20(1):117-9. PubMed ID: 9485566
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
    Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status.
    Kosuge K; Jun Y; Watanabe H; Kimura M; Nishimoto M; Ishizaki T; Ohashi K
    Drug Metab Dispos; 2001 Oct; 29(10):1284-9. PubMed ID: 11560871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Possible inhibitory effect of diazepam on the metabolism of zotepine, an antipsychotic drug.
    Kondo T; Tanaka O; Otani K; Mihara K; Tokinaga N; Kaneko S; Chiba K; Ishizaki T
    Psychopharmacology (Berl); 1996 Oct; 127(4):311-4. PubMed ID: 8923565
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.